These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease. Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860 [TBL] [Abstract][Full Text] [Related]
23. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype. Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609 [TBL] [Abstract][Full Text] [Related]
25. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations. Mbewu AD; Bhatnagar D; Durrington PN; Hunt L; Ishola M; Arrol S; Mackness M; Lockley P; Miller JP Arterioscler Thromb; 1991; 11(4):940-6. PubMed ID: 1829633 [TBL] [Abstract][Full Text] [Related]
26. Lipoprotein(a) in homozygous familial hypercholesterolemia. Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652 [TBL] [Abstract][Full Text] [Related]
27. Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study. Sun D; Li S; Zhao X; Wu NQ; Zhu CG; Guo YL; Gao Y; Qing P; Cui CJ; Liu G; Sun J; Dong Q; Li JJ Metabolism; 2018 Feb; 79():33-41. PubMed ID: 29129821 [TBL] [Abstract][Full Text] [Related]
28. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia. Vuorio A; Watts GF; Kovanen PT Atherosclerosis; 2019 Feb; 281():25-30. PubMed ID: 30616181 [TBL] [Abstract][Full Text] [Related]
29. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia. Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447 [TBL] [Abstract][Full Text] [Related]
30. Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial. Øyri LKL; Hansson P; Bogsrud MP; Narverud I; Florholmen G; Leder L; Byfuglien MG; Veierød MB; Ulven SM; Holven KB Br J Nutr; 2018 May; 119(10):1142-1150. PubMed ID: 29759104 [TBL] [Abstract][Full Text] [Related]
31. Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia. Elisaf M; Bairaktari H; Siamopoulos KC Int J Cardiol; 1996 Mar; 53(3):314-6. PubMed ID: 8793588 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration. Klausen IC; Gerdes LU; Meinertz H; Hansen FA; Faergeman O Eur J Clin Invest; 1993 Apr; 23(4):240-5. PubMed ID: 8500516 [TBL] [Abstract][Full Text] [Related]
33. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia. Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325 [TBL] [Abstract][Full Text] [Related]
34. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease. Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002 [TBL] [Abstract][Full Text] [Related]
35. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia]. Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773 [TBL] [Abstract][Full Text] [Related]
36. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members. Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142 [TBL] [Abstract][Full Text] [Related]
37. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Friedlander Y; Leitersdorf E Genet Epidemiol; 1995; 12(2):129-43. PubMed ID: 7607414 [TBL] [Abstract][Full Text] [Related]
38. SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia. Paquette M; Bernard S; Baass A Clin Biochem; 2019 Apr; 66():44-48. PubMed ID: 30772277 [TBL] [Abstract][Full Text] [Related]